Effects of Remifentanil Gradual Withdrawal Combined with Postoperative Infusion on Postoperative Hyperalgesia in Patients Undergoing Laparoscopic hysterectomy: A Factorial Design, Double-Blind, Randomized Controlled Trial
Meng Luo,Xue Han,Huan Li,Guangyue Zhou,Haoxuan Chen,Fang Gao
DOI: https://doi.org/10.2147/dddt.s451913
IF: 4.3188
2024-02-28
Drug Design Development and Therapy
Abstract:Meng Luo, 1, 2, &ast Xue Han, 1, 2, &ast Huan Li, 1, 2 Guangyue Zhou, 1, 2 Haoxuan Chen, 1, 2 Fang Gao 1, 2 1 Department of Anesthesiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, People's Republic of China; 2 Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical University, Xuzhou, Jiangsu, People's Republic of China &astThese authors contributed equally to this work Correspondence: Fang Gao, Department of Anesthesiology, the Affiliated Hospital of Xuzhou Medical University, No. 99 Huaihai West Road, Xuzhou, Jiangsu, 221002, People's Republic of China, Tel +86-18052268331, Email Background: Remifentanil-induced hyperalgesia (RIH) increases the risk of persistent postoperative pain, making early postoperative analgesic therapy ineffective and affecting postoperative patient satisfaction. This study aimed to verify the effects of gradual withdrawal of remifentanil combined with postoperative pump infusion of remifentanil on postoperative hyperalgesia and pain in patients undergoing laparoscopic hysterectomy. Methods: This trial was a factorial design, double-blind, randomized controlled trial. Patients undergoing laparoscopic hysterectomy were randomly allocated to the control group, postoperative pump infusion of remifentanil group, gradual withdrawal of remifentanil group, or gradual withdrawal plus postoperative pump infusion of remifentanil group (n = 35 each). The primary outcome was postoperative mechanical pain thresholds in the medial forearm. The secondary outcomes included postoperative mechanical pain thresholds around the incision, pain numeric rating scale scores, analgesic utilization, awakening agitation or sedation scores, a 15-item quality of recovery survey, and postoperative complications. Results: Gradual withdrawal of remifentanil significantly increased postoperative pain thresholds versus abrupt discontinuation ( P < 0.05), whereas postoperative infusion did not show significant differences compared to the absence of infusion ( P > 0.05). The combined gradual withdrawal and postoperative infusion group exhibited the highest thresholds and had the lowest postoperative pain scores and analgesic requirements as well as the highest quality of recovery scores ( P < 0.05). No significant differences were observed for agitation scores, sedation scores, or complication rates ( P > 0.05). Conclusion: The novel combined gradual withdrawal and postoperative infusion of remifentanil uniquely attenuates postoperative hyperalgesia, pain severity, analgesic necessity, and improves recovery quality after laparoscopic hysterectomy. Keywords: opioid-induced hyperalgesia, remifentanil-induced hyperalgesia, laparoscopic hysterectomy, mechanical pain thresholds, postoperative recovery Opioid-induced hyperalgesia (OIH) represents a paradoxical reduction in pain thresholds following opioid administration, manifesting primarily as hypersensitivity to painful stimuli. 1 Proposed OIH mechanisms include increased activation of downstream pain pathways by opioids, 2 the induction of long-term potentiation (LTP) at synapses, 3 inflammatory responses with spinal glial cell activation, 4 the role of endogenous neuropeptides, 5 alterations in opioid receptor function and number 6 and reduced function of inhibitory neurotransmitter receptors 7 among others. Studies have shown that chronic pain occurs in about 5–32% of hysterectomy patients. 8 Inadequate perioperative analgesia and unchecked hyperalgesia engender significant risk for the development of intractable postoperative pain syndromes. 9 Remifentanil possesses unique pharmacokinetic properties, including rapid onset, fleeting half-life, and independence of hepatic and renal clearance, allowing for sustained infusion without bioaccumulation. This pharmacologic profile has enabled the widespread utilization of remifentanil for both acute and chronic analgesia as well as the maintenance of general anesthesia. 10 However, investigations have revealed that among opioid analgesics, remifentanil elicits the highest rates of OIH. 11 In recent years, diverse pharmacological interventions such as ketamine, colistin, non-steroidal anti-inflammatory drugs (NSAIDs), nitric oxide, and magnesium sulfate have demonstrated efficacy in attenuating remifentanil-induced hyperalgesia (RIH) to varying extents in animal models and clinical trials. 12–16 However, supplemental dosing regimens introduce the potential fo -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal